Deerfield Management Company as of Sept. 30, 2011
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 63 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Express Scripts | 7.7 | $37M | 1.0M | 37.07 | |
| Walgreen Company | 6.8 | $33M | 1.0M | 32.89 | |
| Merck & Co (MRK) | 6.4 | $31M | 950k | 32.70 | |
| Aetna | 6.1 | $30M | 815k | 36.34 | |
| CVS Caremark Corporation (CVS) | 5.5 | $27M | 798k | 33.59 | |
| Medco Health Solutions | 5.1 | $25M | 525k | 46.89 | |
| Humana (HUM) | 5.0 | $24M | 336k | 72.73 | |
| Centene Corporation (CNC) | 4.5 | $22M | 770k | 28.67 | |
| Hill-Rom Holdings | 3.9 | $19M | 623k | 30.02 | |
| ZOLL Medical Corporation | 3.8 | $18M | 488k | 37.74 | |
| St. Jude Medical | 3.7 | $18M | 500k | 36.19 | |
| Bristol Myers Squibb (BMY) | 3.6 | $17M | 550k | 31.38 | |
| Gen-Probe Incorporated | 3.5 | $17M | 300k | 57.25 | |
| Cardinal Health (CAH) | 2.9 | $14M | 334k | 41.88 | |
| MAP Pharmaceuticals | 2.3 | $11M | 771k | 14.62 | |
| Stryker Corporation (SYK) | 2.2 | $11M | 231k | 47.13 | |
| Eli Lilly & Co. (LLY) | 1.9 | $9.2M | 250k | 36.97 | |
| Amarin Corporation (AMRN) | 1.8 | $8.9M | 969k | 9.20 | |
| AMERIGROUP Corporation | 1.8 | $8.6M | 220k | 39.01 | |
| McKesson Corporation (MCK) | 1.7 | $8.3M | 114k | 72.70 | |
| Kindred Healthcare | 1.5 | $7.4M | 858k | 8.62 | |
| Triple-S Management | 1.5 | $7.4M | 443k | 16.75 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $6.7M | 150k | 44.47 | |
| Cardiovascular Systems | 1.3 | $6.5M | 571k | 11.39 | |
| Ardea Biosciences | 1.1 | $5.2M | 334k | 15.62 | |
| Cephalon | 0.9 | $4.6M | 57k | 80.70 | |
| Conceptus | 0.9 | $4.2M | 398k | 10.47 | |
| Metropolitan Health Networks | 0.9 | $4.2M | 920k | 4.54 | |
| Rockwell Medical Technologies | 0.8 | $3.9M | 480k | 8.16 | |
| Anthera Pharmaceuticals | 0.8 | $3.8M | 800k | 4.77 | |
| BioScrip | 0.7 | $3.2M | 500k | 6.36 | |
| Derma Sciences | 0.7 | $3.2M | 407k | 7.79 | |
| Tenet Healthcare Corporation | 0.6 | $3.1M | 757k | 4.11 | |
| Amgen (AMGN) | 0.6 | $3.1M | 56k | 54.96 | |
| Universal Health Realty Income Trust (UHT) | 0.6 | $3.0M | 90k | 33.61 | |
| Covidien | 0.5 | $2.3M | 53k | 44.10 | |
| Biolase Technology | 0.5 | $2.2M | 728k | 3.00 | |
| WellPoint | 0.4 | $2.1M | 33k | 65.27 | |
| Amgen (AMGN) | 0.4 | $1.9M | 35k | 54.96 | |
| Medivation | 0.3 | $1.7M | 100k | 16.98 | |
| Acelrx Pharmaceuticals | 0.3 | $1.4M | 436k | 3.21 | |
| Five Star Quality Care | 0.3 | $1.3M | 538k | 2.50 | |
| BioSante Pharmaceuticals | 0.3 | $1.3M | 550k | 2.28 | |
| NuVasive | 0.2 | $1.2M | 71k | 17.06 | |
| Keryx Biopharmaceuticals | 0.2 | $1.1M | 380k | 3.00 | |
| Biogen Idec (BIIB) | 0.2 | $1.0M | 11k | 93.11 | |
| Healthsouth | 0.2 | $1.1M | 70k | 14.93 | |
| Gilead Sciences (GILD) | 0.2 | $970k | 25k | 38.80 | |
| Molina Healthcare (MOH) | 0.2 | $984k | 64k | 15.43 | |
| Momenta Pharmaceuticals | 0.2 | $907k | 79k | 11.50 | |
| Auxilium Pharmaceuticals | 0.1 | $675k | 45k | 15.00 | |
| Acorda Therapeutics | 0.1 | $599k | 30k | 19.97 | |
| Delcath Systems | 0.1 | $490k | 147k | 3.34 | |
| NeurogesX | 0.1 | $485k | 545k | 0.89 | |
| Cleveland BioLabs | 0.1 | $484k | 191k | 2.53 | |
| Warner Chilcott Plc - | 0.1 | $406k | 28k | 14.30 | |
| Tearlab Corp | 0.1 | $371k | 412k | 0.90 | |
| D Tranzyme | 0.1 | $403k | 153k | 2.64 | |
| Neostem (NBS) | 0.1 | $245k | 377k | 0.65 | |
| BSD Medical Corporation | 0.0 | $73k | 27k | 2.67 | |
| Somaxon Pharmaceuticals | 0.0 | $38k | 44k | 0.86 | |
| Apricus Bioscience | 0.0 | $72k | 20k | 3.60 | |
| USD.001 Ibio | 0.0 | $57k | 36k | 1.60 |
